Showing 5,869 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Resistance

High rates of HIV drug resistance among young people in London will limit future treatment options

News
8 May 2025
Access to healthcare

Reducing dosing: a possible crisis response to ART stock-outs and closed clinics

Editor's pick
i-Base
5 May 2025
Weight gain & lipodystrophy

Semaglutide may slow ageing, improve cognition and curb alcohol use

News
28 April 2025
People with limited treatment options

Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years

Editor's pick
i-Base
22 April 2025
Injectable & long-acting HIV treatment

Potential for bictegravir and dolutegravir to overcome resistance to CAB/RPV-LA

Editor's pick
i-Base
14 April 2025
Sexually transmitted infections epidemiology

CDC’s top laboratory on sexually transmitted diseases is shut by Trump administration

Editor's pick
STAT
7 April 2025
Menopause

Addressing Menopause in Women Living With HIV: Update From CROI 2025

Editor's pick
TheBodyPro
3 April 2025
Health problems & ageing

Aging with HIV in Botswana: Time to Update Our Treatment Guidelines

Editor's pick
HIV Science and Advocacy (blog)
2 April 2025
Bad science & bogus treatments

Should we care that the FDA is going after poppers?

Editor's pick
San Francisco AIDS Foundation
26 March 2025
PrEP policies & guidelines

Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach

News
20 March 2025
Injectable & long-acting HIV treatment

Uganda's experiences implementing long-acting injectable ART to combat HIV/AIDS

Editor's pick
Be In The Know
19 March 2025
Injectable & long-acting HIV treatment

Long-Acting Injectables Work Well for People Without Viral Suppression

Editor's pick
POZ
19 March 2025
New & experimental HIV treatments

ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV

Editor's pick
GlobeNewswire
18 March 2025
PrEP science

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

News
17 March 2025
Injectable & long-acting HIV treatment

New long-acting HIV drugs show promising early results

News
17 March 2025
Antibody-based treatment

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

News
17 March 2025
Treatment simplification strategies

Reducing Biktarvy from daily to only once, twice or three times a week

Editor's pick
i-Base
17 March 2025
Adherence

Urine testing plus feedback can increase PrEP adherence in pregnant women

Editor's pick
Healio
17 March 2025
Low CD4 count

Treatment Options for People With Advanced HIV Disease at Diagnosis: Interview With Georg Behrens, M.D., Ph.D.

Editor's pick
TheBodyPro
17 March 2025
Chemsex & recreational drug use

FDA reportedly raids manufacturer of poppers, an increasingly popular party drug

Editor's pick
NBC News
17 March 2025
New & experimental HIV treatments

Studies confirm non-inferiority of doravirine / islatravir to standard HIV treatment

News
17 March 2025
Retention & linkage to care

PEPFAR study shows the deadly impact of stopping children’s HIV treatment

News
12 March 2025
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

News
12 March 2025
Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

News
12 March 2025